Correlation between the presence of anti HPV33 VLP antibodies and HPV DNA in cervical neoplasia patients

Archives of Virology

Volumn 142, Issue 2, 1997, Pages 413-416

  Hamsikova E ^a   Smahel M ^a   Sapp, M ^b   Munoz N ^c   Bosch, F X ^d   Shah, K V ^e   Vonka, V ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c IARC   (France)

^d CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA;

ARTICLE; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; UTERINE CERVIX CARCINOMA IN SITU; VIRION; VIROLOGY;

ANTIBODIES, VIRAL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; VIRION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 33; INSECTA; MIRIDAE; PAPILLOMAVIRUS; UNIDENTIFIED BACULOVIRUS;

EID: 0031056504     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050087     Document Type: Article

References (16)

1. Bosch FX, Muńoz N, de Sanjose S, Navarro C, Moreo P, Ascunce N, Gonzalez LC, Tafur L, Gili M, Larranaga l Viladiu P, Daniel RW, deRuiz PA, Aristizabal N, Santamaria M, Guerrero E, Shah KV (1993) Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 2: 415-422
2. Carter JJ, Hagensee M, Taflin MC, Lee SK, Koutsky LA, Galloway DA (1993) HPV-1 capsids expressed in vitro detect human serum antibodies associated with foot warts. Virology 195: 456-462
3. Christensen ND, Höpfl R, DiAngelo SL, Cladel NM, Patrick SD, Welsh PA, Budgeon LR, Reed CA, Kreider JW (1994) Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by a neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. J Gen Virol 75: 2271-2276
4. Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, Anderson M, Kocjan G, Steele ST, Guillebaud J (1995) Human papillomavirus testing in primary cervical screening. Lancet 345: 1533-1536
5. Dillner J, Kallings I, Brihmer C, Sikstrom P, Koskela P, Lehtinen M, Schiller JT, Sapp M, Mardh PA (1996) Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J Infect Dis 173: 1394-1398
6. Dillner J, Wiklund F, Lenner P, Eklund C, Frederiksson-Shanazarian V, Schiller JT, Hibma M, Hallmans G, Stendahl U (1995) Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer. Int J Cancer 60: 377-382
7. Galloway DA (1992) Serological assays for the detection of HPV antibodies. In: Munoz N, Bosch FX, Shah KV, Meheus A (eds) The epidemiology of cervical cancer and human papillomaviruses. IARC, Lyon, pp 147-159
8. Hagensee ME, Yaegashi N, Galloway DA (1993) Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol 67: 315-322
9. Hamšiková E, Novák J, Hofmannová V, Muńoz N, Bosch FX, de Sanjose S, Shah K, Roth Z Vonka V (1994) Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls. J Infect Dis 170: 1424-1431
10. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT (1994) A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 86: 494-499
11. Muńoz N, Bosch FX, de Sanjose S, Tafur L, Izarzugaza L, Gili M, Viladiu P, Navarro C, Martos C, Ascunce N, Golzales LC, Kaldor KM, Guerrero E, Lorincz A, Santamaria M, de Ruiz PA, Aristizabal N, Shah KV (1992) The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 52: 743-749
12. Nonnenmacher B, Hubbert NL, Kirnbauer R, Shah KV, Muńoz N, Bosch FX, de Sanjose S, Viscidi R, Lowy DR, Schiller JT (1995) Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. J Infect Dis 172: 19-24
13. Rose RC, Bonnez W, Reichman RC, Garcea RL (1993) Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of virus-like particles. J Virol 67: 1936-1944
14. Schiller JT, Roden RBS (1995) Papillomavirus-like particles. Papillomavirus Rep 6: 121-128
15. Steele JC, Gallimore PH (1990) Humoral assays of human sera to disrupted and nondisrupted epitopes of human papillomavirus type 1. Virology 174: 388-398
16. Volpers C, Schirmacher P, Streeck RE, Sapp M (1994) Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. Virology 200: 504-512